Literature DB >> 999311

Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases.

J P Byrne, M Hewitt, R Summerly.   

Abstract

In two patients, active chronic hepatitis was complicated by the development of pyoderma gangrenosum. The favorable response of the pyodermatous lesions to azathioprine therapy suggests that this drug may be of value in treating this disorder in patients for whom corticosteroid therapy produces no benefit or is contraindicated because of side effects. Azathioprine, too, is a potentially toxic drug and may need to be discontinued. Possible causal relationships between pyoderma gangrenosum and active chronic hepatitis are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 999311

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Pyoderma gangrenosum with cellular immunity defect and red cell aplasia.

Authors:  R Clayton
Journal:  Proc R Soc Med       Date:  1977-08

3.  Treatment of pyoderma gangrenosum with disodium cromoglycate.

Authors:  B Saffouri; B M Hom; J M Mertesdorf; J E Gardiner
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

4.  Pyoderma Gangrenosum-A New Manifestation of Wilson Disease?

Authors:  George Naiem Ibrahiem Freg; Venisha Shah; Aabha Nagral; Ajay Jhaveri
Journal:  J Clin Exp Hepatol       Date:  2015-12-08

Review 5.  Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease.

Authors:  A P Ruhl; J E Ganz; S J Bickston
Journal:  Dig Dis Sci       Date:  2006-12-08       Impact factor: 3.487

Review 6.  Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Pietro Invernizzi; M Eric Gershwin; Carlo Mainetti
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.